Search

Your search keyword '"Di Marino, P"' showing total 339 results

Search Constraints

Start Over You searched for: Author "Di Marino, P" Remove constraint Author: "Di Marino, P"
339 results on '"Di Marino, P"'

Search Results

101. Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report

102. The KM3NeT potential for the next core-collapse supernova observation with neutrinos: KM3NeT Collaboration

103. Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren’s Syndrome

104. Insights Into the Binding Mechanism of GC7 to Deoxyhypusine Synthase in Sulfolobus solfataricus: A Thermophilic Model for the Design of New Hypusination Inhibitors

105. Chemical, Functional, and Technological Features of Grains, Brans, and Semolina from Purple and Red Durum Wheat Landraces

106. A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome

108. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

109. La Educación Sexual Integral y la Perspectiva de Género en la Formación de Profesorxs de Biología: un análisis desde las voces de lxs estudiantes

110. Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds

111. Binding of the Anti-FIV Peptide C8 to Differently Charged Membrane Models: From First Docking to Membrane Tubulation

112. Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?

113. Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

114. Mobile Robots and Cobots Integration: A Preliminary Design of a Mechatronic Interface by Using MBSE Approach

115. Improving basic skills in celiac-like disease diagnosis: a case report

116. Conservation of The Historical Town of Izmit Through The Restoration of Pertev Mehmet Pasha Mosque

117. Collaborative Workplace Design: A Knowledge-Based Approach to Promote Human–Robot Collaboration and Multi-Objective Layout Optimization

118. Author Correction: Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association

119. Orbital apocrine hidrocystoma. Report of two cases

120. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

121. Pin1 as Molecular Switch in Vascular Endothelium: Notes on Its Putative Role in Age-Associated Vascular Diseases

122. Prospective investigation of FOXP1 syndrome

123. Correction: Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression

124. Fast Digital Phase Detection of a Coherent Tone At GHz Frequencies

125. Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

127. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

130. Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406](S2059702922000278)(10.1016/j.esmoop.2022.100406)

131. Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy

132. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

133. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study

134. The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer

135. Bioelectrical impedance analysis in patients with posterior vitreous detachment.

137. Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase

138. Neuroprotection by MKK7 inhibition in excitotoxicity

139. Salivary Metabolome and Soccer Match: Challenges for Understanding Exercise induced Changes

140. Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

141. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

142. Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

145. Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406]

146. Effects of Dried Blood Spot Storage on Lipidomic Analysis

148. Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]

149. Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078]

150. 68P High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients

Catalog

Books, media, physical & digital resources